Dr. Blair Jobe
Surgical OncologistDr. Blair Jobe at Allegheny Health Network in Pittsburgh is known as a prolific medical researcher and one of the country’s preeminent specialists in esophageal disease.
-
Allegheny General Hospital Pittsburgh, Pennsylvania (PA)
-
Primary Location:Allegheny General Hospital -
Expertise:Esophageal Cancer
Trachea Disorders -
Speciality:Surgical Oncology -
Gender:Male -
Language:English -
Med School:Loyola Marymount University, Creighton University School of Medicine
Get to Know Dr. Blair Jobe
Dr. Blair Jobe is director of the Allegheny Health Network Esophageal and Lung Institute in Pittsburgh and a pioneer in the field of minimally invasive surgery.
Jobe is one of the country’s preeminent specialists in endoscopic therapy for the treatment of esophageal cancer. He also handles cases of malignant pleural mesothelioma.
As a prolific medical researcher, he has been the principal investigator for two large grants from the National Institutes of Health that focused on early detection of esophageal disease. The research includes the development of tissue and serum biomarkers.
Earlier in his career he was honored with a Health Care Heroes Award for his discovery of four protein biomarkers that later became an accurate and inexpensive way to determine whether esophageal cancer was present.
Specialties of Dr. Blair Jobe
- Esophageal cancer
- Esophageal motility disorders
- Dysplasia
- Barrett’s esophagus
- Achalasia
- Tracheal disorders
Dr. Blair Jobe’s Experience and Medical Education
- Allegheny Health Network
- University of Pittsburgh Medical Center
- American Board of Surgery
- Creighton University School of Medicine (M.D.)
- Oregon Health & Science University (Residency)
- Swedish Medical Center, Seattle (Fellowship)
Awards and Other Recognitions
- Health Care Heroes Award, Pittsburgh Business Times
- Outstanding Researcher of the Year Award, Society of American Gastrointestinal and Endoscopic Surgeons
Publications of Dr. Blair Jobe
- Babar, L. et al. (2019, July 16). Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma. Oncotarget.
- Kelly, R.J. et al. (2018, December 26). The Dynamic and Transient Immune Microenvironment in Locally Advanced Esophageal Adenocarcinoma Post Chemoradiation. Annals of Thoracic Surgery.
- Komatsu, Y., Newhams, K.M. & Jobe, B.A. (2018, November 28). Enhancing the Detection of Barrett Esophagus. Thoracic Surgery Clinic.
- Alicuben, E.T. et al. (2018, April 17). Worldwide Experience with Erosion of the Magnetic Sphincter Augmentation Device. Journal of Gastrointestinal Surgery.
Watch Our Free Mesothelioma Webinars
Find Active Mesothelioma Clinical Trials
Mesothelioma Trust Funds
